Mochida Pharmaceutical Co (FRA:MFY) EPS (Basic) : €0.81 (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Mochida Pharmaceutical Co EPS (Basic)?

Mochida Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Dec. 2023 was €0.29. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.81.

Mochida Pharmaceutical Co's EPS (Diluted) for the three months ended in Dec. 2023 was €0.29. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.81.

Mochida Pharmaceutical Co's EPS without NRI for the three months ended in Dec. 2023 was €0.29. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was 0.79.

During the past 12 months, Mochida Pharmaceutical Co's average EPS without NRIGrowth Rate was -29.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was -18.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was -5.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was -3.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Mochida Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 38.90% per year. The lowest was -18.40% per year. And the median was 2.80% per year.

Mochida Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Mochida Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mochida Pharmaceutical Co EPS (Basic) Chart

Mochida Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EPS (Basic)

Get a 7-Day Free Trial

0.99

1.72

2.12

1.25

0.78

Mochida Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EPS (Basic)	Get a 7-Day Free Trial															-0.26	0.30	0.20	0.29	0.02

Mochida Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Mochida Pharmaceutical Co's Basic EPS for the fiscal year that ended in Mar. 2024 is calculated as

Basic EPS (A: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(27.922	-	0)	/	35.860
	=	0.78

Mochida Pharmaceutical Co's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(10.228	-	0)	/	35.559
	=	0.29

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.81

Mochida Pharmaceutical Co (FRA:MFY) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Mochida Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Mochida Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Mochida Pharmaceutical Co (FRA:MFY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mochida Pharmaceutical Co Ltd (FRA:MFY) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

4534:Japan

Address

1-1 Ichigayahonmuracho, Shinjuku-ku, Tokyo, JPN, 162-0845

Website

http://www.mochida.co.jp

Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.

Mochida Pharmaceutical Co (FRA:MFY) Headlines

No Headlines